Ablacon Competitors and Similar CompaniesClear all
Ablacon's competitors and similar companies include FibriCheck and Corhythm.
 FibriCheck FibriCheck is a medically certified screening and monitoring application on prescription for the detection of irregular heart rhythms, including atrial fibrillatio |  Corhythm Corhythm is an early stage company developing a novel therapy for the treatment of atrial fibrillation. | ||
Founding Date | Founding Date 2015 | Founding Date 2014 | Founding Date 2006 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Wheat Ridge, US HQ Munich, DE Blonay, CH | Locations Hasselt, BE HQ | Locations San Antonio, US HQ |
Employees | Employees 128% decrease | Employees 323% decrease | Employees 1 |
Funding | |||
Latest funding round | Latest funding round $ 10m (almost 7 years ago) | Latest funding round $ 1.6m (about 9 years ago) | Latest funding round $ 1.6m (over 8 years ago) |
Total funding raised | Total funding raised $ 33.5m | Total funding raised $ 1.7m | Total funding raised $ 3.9m |
For sources of this data, please see the company profile
View Company Profiles
FibriCheck
HQ
Hasselt, BE
Employees
32↓ 3% decrease
FibriCheck is a medically certified screening and monitoring application on prescription for the detection of irregular heart rhythms, including atrial fibrillatio
View companyCorhythm
HQ
San Antonio, US
Employees
1
Corhythm is an early stage company developing a novel therapy for the treatment of atrial fibrillation.
View company